Form 8-K - Current report:
SEC Accession No. 0001193125-25-162969
Filing Date
2025-07-23
Accepted
2025-07-23 08:15:35
Documents
14
Period of Report
2025-07-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d21770d8k.htm   iXBRL 8-K 37804
2 EX-2.1 d21770dex21.htm EX-2.1 15772
  Complete submission text file 0001193125-25-162969.txt   213224

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20250722.xsd EX-101.SCH 3911
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20250722_def.xml EX-101.DEF 13701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20250722_lab.xml EX-101.LAB 22563
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20250722_pre.xml EX-101.PRE 14670
17 EXTRACTED XBRL INSTANCE DOCUMENT d21770d8k_htm.xml XML 5678
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 251141672
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)